Sorry, you need to enable JavaScript to visit this website.

Japan

Top Management

Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree

As of April 1, 2019

Group Management Structure

Group Management Structure

 

Executive Committee

Standing Members

Chief Executive Officer (CEO) Kenji Yasukawa
Chief Strategy Officer (CStO) Naoki Okamura
Chief Financial Officer (CFO) Chikashi Takeda
Chief Administrative Officer &
Chief Ethics & Compliance Officer (CAO & CECO)		 Fumiaki Sakurai
General Counsel (GC) Linda Friedman
Chief Medical Officer (CMO) Bernie Zeiher
Chief Commercial Officer (CCO) Yukio Matsui

 

Extended Members

President, Drug Discovery Research Akihiko Iwai
President, Pharmaceutical Technology Hideki Shima
President, Development Steven Benner
President, Established Markets Commercial Dirk Kosche
President, Greater China Commercial Hiroshi Hamaguchi
President, International Commercial Yukio Matsui 
President, Japan Commercial Nobuaki Tanaka
President, US Commercial Percival Barretto-Ko